DV Biomed Price To Book vs. Revenue

6539 Stock  TWD 66.90  0.20  0.30%   
Based on the measurements of profitability obtained from DV Biomed's financial statements, DV Biomed Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess DV Biomed's ability to earn profits and add value for shareholders.
For DV Biomed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DV Biomed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DV Biomed Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DV Biomed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DV Biomed Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between DV Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if DV Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DV Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

DV Biomed Revenue vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining DV Biomed's current stock value. Our valuation model uses many indicators to compare DV Biomed value to that of its competitors to determine the firm's financial worth.
DV Biomed Co is number one stock in price to book category among its peers. It also is the top company in revenue category among its peers totaling about  543,543,544  of Revenue per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DV Biomed's earnings, one of the primary drivers of an investment's value.

6539 Revenue vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

DV Biomed

P/B

 = 

MV Per Share

BV Per Share

 = 
3.33 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

DV Biomed

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
1.81 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

6539 Revenue vs Competition

DV Biomed Co is the top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 94.17 Billion. DV Biomed claims roughly 1.81 Billion in revenue contributing just under 2% to equities under Drug Manufacturers—Specialty & Generic industry.

DV Biomed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in DV Biomed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DV Biomed will eventually generate negative long term returns. The profitability progress is the general direction of DV Biomed's change in net profit over the period of time. It can combine multiple indicators of DV Biomed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company was founded in 2011 and is based in Taipei, Taiwan. UnicoCell operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.

6539 Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on DV Biomed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DV Biomed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DV Biomed's important profitability drivers and their relationship over time.

Use DV Biomed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DV Biomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will appreciate offsetting losses from the drop in the long position's value.

DV Biomed Pair Trading

DV Biomed Co Pair Trading Analysis

The ability to find closely correlated positions to DV Biomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DV Biomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DV Biomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DV Biomed Co to buy it.
The correlation of DV Biomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DV Biomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DV Biomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DV Biomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your DV Biomed position

In addition to having DV Biomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Software Thematic Idea Now

Software
Software Theme
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for 6539 Stock Analysis

When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.